Veterinary Medicines

VITAMINS AD3E/ANAFASIS, ενέσιμο ελαιώδες διάλυμα για βοοειδή, ιπποειδή, χοίροι, αίγες, πρόβατα, νεαροί σκύλοι

Authorised
  • TOCOPHERYL ACETATE
  • Colecalciferol
  • Retinol palmitate
Download as PDF

Product identification

Medicine name:
VITAMINS AD3E/ANAFASIS, ενέσιμο ελαιώδες διάλυμα για βοοειδή, ιπποειδή, χοίροι, αίγες, πρόβατα, νεαροί σκύλοι
Active substance:
  • TOCOPHERYL ACETATE
  • Colecalciferol
  • Retinol palmitate
Target species:
  • Cattle
  • Pig
  • Horse
  • Sheep
  • Goat
  • Dog
Route of administration:
  • Intramuscular and intravenous use

Product details

Active substance and strength:
  • TOCOPHERYL ACETATE
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Colecalciferol
    25000.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Retinol palmitate
    50000.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular and intravenous use
    • Cattle
      • Meat and offal
        231
        day
      • Milk
        120
        hour
    • Pig
      • Meat and offal
        200
        day
    • Horse
      • Meat and offal
        231
        day
      • Milk
        120
        hour
    • Sheep
      • Meat and offal
        200
        day
      • Milk
        120
        hour
    • Goat
      • Meat and offal
        200
        day
      • Milk
        120
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA11JA
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Anafasis Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Uplab Pharmaceutical Company Ltd.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 85823/14-12-2015/K-0002902
Date of authorisation status change: